Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with HypertensionRADNOR, PA – January 8, 2025 – Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company fo
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Mineralys Therapeutics’s 8K filing here. Mineralys Therapeutics Company Profile (Get Free Report) Mineralys Therapeutics, Inc, a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and chronic kidney diseases. It […]
More Stories
TD SYNNEX (NYSE:SNX) Stock Price Up 5.4% – Should You Buy?
Shares of TD SYNNEX Co. (NYSE:SNX – Get Free Report) were up 5.4% on Friday . The stock traded as...
Endeavour Silver (NYSE:EXK) Trading 6.2% Higher – Should You Buy?
Endeavour Silver Corp. (NYSE:EXK – Get Free Report) (TSE:EDR) shot up 6.2% during mid-day trading on Friday . The company...
LyondellBasell Industries (NYSE:LYB) Shares Purchased by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its holdings in LyondellBasell Industries (NYSE:LYB – Free Report) by 20.2% during the 4th quarter, according...
Schwab Short-Term U.S. Treasury ETF (NYSEARCA:SCHO) Shares Bought by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its stake in shares of Schwab Short-Term U.S. Treasury ETF (NYSEARCA:SCHO – Free Report) by 98.5%...
Ridgewood Investments LLC Decreases Holdings in Invesco S&P International Developed Low Volatility ETF (NYSEARCA:IDLV)
Ridgewood Investments LLC trimmed its stake in shares of Invesco S&P International Developed Low Volatility ETF (NYSEARCA:IDLV – Free Report)...
Smith & Nephew plc (NYSE:SNN) Stock Position Lifted by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its stake in shares of Smith & Nephew plc (NYSE:SNN – Free Report) by 6.1% during...